文献速递乳房整形与再造美容整形

乳房假体取出术患者自报健康症状的回顾性分析

Self-Reported Health Complaints in Women Undergoing Explantation of Breast Implants.
PubMed 文献 · Aesthet Surg J · 2022-01-01

该研究回顾了2010至2020年Maastricht大学医学中心行乳房假体取出术的患者,发现超过半数有主诉(多为疼痛),约15%自报全身症状,乳房假体病(BII)为第五常见取出指征(11.2%)。过敏史或假体破裂者BII风险增高(OR均为2.1),约60%BII患者取出后主观改善。

要点

  • 乳房假体取出患者中约15%自报全身症状,BII占取出指征11.2%。
  • 过敏史或假体破裂与BII风险增高相关(OR均为2.1)。
  • 约60%BII患者取出假体后症状主观改善,自体重建是良好替代方案。

核心结论

  • 接受乳房假体取出的女性中,疑似BII的患病率相对较低,约1/9手术因此原因进行。
  • 过敏史和假体破裂可能增加BII的可能性,约60%BII患者取出后主诉改善。
  • 自体重建似乎是良好替代方案,需前瞻性研究确认取出术对BII的疗效。

研究设计与样本

  • 回顾性病历审查,纳入2010至2020年Maastricht大学医学中心行乳房假体取出术的患者。
  • 排除组织扩张器取出、扩张器-假体置换或直接假体置换的患者。

主要发现

  • 超过半数取出患者报告主诉,主要为疼痛;约15%报告自认为与假体相关的全身症状。
  • BII为第五常见取出指征,占11.2%。
  • 过敏史或假体破裂者BII的比值比均为2.1。
  • 约60%BII患者报告取出后主观改善。

临床怎么用

  • 对要求取出假体的患者,应评估过敏史和假体破裂情况,其与BII风险相关。
  • 告知BII患者约60%取出后症状可能主观改善,自体重建可作为替代选择。

局限性

  • 需前瞻性研究探究健康主诉与生活质量,以确认取出术作为BII治疗的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concerns about the safety of silicone breast implants (SBIs) have existed for years, but a causal relation between systemic complaints and SBIs has not been proven. Nevertheless, some women are worried and even request explantation. OBJECTIVES: This study aimed to review the explantation procedures performed, focusing on patient-reported symptoms preoperatively, the effect of explantation, and the effect of breast reconstruction on these symptoms. METHODS: A retrospective chart review was performed for patients who had undergone explantation between 2010 and 2020 at Maastricht University Medical Center. Patients who had undergone tissue expander removal, tissue expander-implant exchange, or direct implant exchange were excluded. RESULTS: More than half of the patients undergoing explantation reported complaints, mostly pain. Some 15% reported systemic complaints they believed were implant related. Breast implant illness (BII) was found to be the fifth most common indication for explantation (11.2%). A history of either allergies or implant rupture resulted in higher odds ratios of having BII (odd ratios, 2.1 and 2.1, respectively). Subjective improvement of BII after explantation was reported by about 60% of patients. CONCLUSIONS: A relatively low prevalence of suggested BII exists among women undergoing explantation; 1 in 9 procedures were performed for this reason. Allergy and implant rupture may increase the likelihood of having BII. About 60% of BII patients experienced an improvement in their complaints after implant removal. Autologous breast reconstruction appears a good alternative. Prospective studies into health complaints and quality of life should be performed to confirm the effectiveness of explantation as a therapy for BII.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Miseré RML, van der Hulst RRWJ. Self-Reported Health Complaints in Women Undergoing Explantation of Breast Implants. Aesthet Surg J. 2022. PMID: 33252630. doi:10.1093/asj/sjaa337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。